Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
Clinical trial NCT01269853 · RECRUITING
Trial details
- NCT number
- NCT01269853
- Sponsor
- Northwell Health
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2028-10-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.